These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28112869)

  • 1. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.
    Ostos FJ; Lebrón JA; Moyá ML; López-López M; Sánchez A; Clavero A; García-Calderón CB; Rosado IV; López-Cornejo P
    Chem Asian J; 2017 Mar; 12(6):679-689. PubMed ID: 28112869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
    Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
    J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating a Thermoresponsive Multimodal Photo-Chemotherapeutic Nanodelivery Vehicle to Overcome the Barriers of Doxorubicin Therapy.
    Nair JB; Joseph MM; Arya JS; Sreedevi P; Sujai PT; Maiti KK
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43365-43379. PubMed ID: 32880178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilayer Nanocarriers with Protein-Acid Conjugation for Prolonged Release and Enhanced Anticancer Effects.
    Hou H; Zhang D; Zeng J; Zhou L; Wang Z; Yao M; Ren J; Hu N; Wang Y
    Langmuir; 2019 Mar; 35(10):3710-3716. PubMed ID: 30727729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of
    Li Y; Angelova A; Hu F; Garamus VM; Peng C; Li N; Liu J; Liu D; Zou A
    Langmuir; 2019 Nov; 35(45):14532-14542. PubMed ID: 31635451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needle-shaped amphoteric calix[4]arene as a magnetic nanocarrier for simultaneous delivery of anticancer drugs to the breast cancer cells.
    Rahimi M; Karimian R; Noruzi EB; Ganbarov K; Zarei M; Kamounah FS; Yousefi B; Bastami M; Yousefi M; Samadi Kafil H
    Int J Nanomedicine; 2019; 14():2619-2636. PubMed ID: 31043778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
    Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
    Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of folic acid conjugated hollow silica nanoparticles toward Caco2 and 3T3 cells, with and without encapsulated DOX.
    Patel K; Sundara Raj B; Chen Y; Lou X
    Colloids Surf B Biointerfaces; 2016 Apr; 140():213-222. PubMed ID: 26764104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclodextrin derivatives conjugated with aromatic moieties as pH-responsive drug carriers for anthracycline.
    Swiech O; Dutkiewicz P; Wójciuk K; Chmurski K; Kruszewski M; Bilewicz R
    J Phys Chem B; 2013 Oct; 117(43):13444-50. PubMed ID: 24079546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell deformation and acquired drug resistance: elucidating the major influence of drug-nanocarrier delivery systems.
    Nandi S; Kale NR; Takale V; Chate GC; Bhave M; Banerjee SS; Khandare JJ
    J Mater Chem B; 2020 Mar; 8(9):1852-1862. PubMed ID: 32022091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
    Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
    Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
    Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
    Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery.
    Alexander CM; Hamner KL; Maye MM; Dabrowiak JC
    Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabricating an intelligent cell-like nano-prodrug via hierarchical self-assembly based on the DNA skeleton for suppressing lung metastasis of breast cancer.
    Li Y; Yan T; Chang W; Cao C; Deng D
    Biomater Sci; 2019 Aug; 7(9):3652-3661. PubMed ID: 31169833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
    Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
    Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.